Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe Locations section expanded with numerous new sites across multiple countries and regions, while many existing sites were removed, altering geographic coverage of the trial.SummaryDifference3%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedPublications section updated to clarify PubMed auto-fill and the revision tag updated to v3.3.2.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding status notice at the top of the page has been removed. It previously stated that the NIH Clinical Center is open and provided links to operating status updates.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded two Taiwan sites in Tainan (704 and 736) and removed the corresponding Tainan City entries (704 and 736) from the Locations section.SummaryDifference0.0%

- Check56 days agoChange DetectedThe changes are limited to administrative updates such as the last updated date and minor formatting; there are no changes to core study information like eligibility criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedSummary: The page now displays a government funding lapse notice and new operating status details accompanying a version upgrade to v3.2.0, replacing the old v3.1.0.SummaryDifference1.0%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.